The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HEMO HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01




Time/Date Code Headline Source Impact
07:00 15-Nov-2017 HEMO Directorate Change RNS +11.61% Up
07:00 14-Nov-2017 HEMO Notice of AGM RNS +20.24% Up
16:40 13-Nov-2017 HEMO Second Price Monitoring Extn RNS +22.55% Up
16:35 13-Nov-2017 HEMO Price Monitoring Extension RNS +22.55% Up
14:05 13-Nov-2017 HEMO Second Price Monitoring Extn RNS +22.55% Up
14:00 13-Nov-2017 HEMO Price Monitoring Extension RNS +22.55% Up
11:05 13-Nov-2017 HEMO Second Price Monitoring Extn RNS +22.55% Up
11:00 13-Nov-2017 HEMO Price Monitoring Extension RNS +22.55% Up
09:05 13-Nov-2017 HEMO Second Price Monitoring Extn RNS +22.55% Up
09:00 13-Nov-2017 HEMO Price Monitoring Extension RNS +22.55% Up
07:00 13-Nov-2017 HEMO Statement re Press Comment RNS +22.55% Up
07:00 30-Oct-2017 HEMO LakePharma appointed for lead product development RNS -5.41% Down
07:00 11-Oct-2017 HEMO Director/PDMR Shareholding RNS +29.79% Up
07:00 10-Oct-2017 HEMO Director/PDMR Shareholding RNS +41.45% Up
08:01 05-Oct-2017 HEMO Cornell University update RNS -
08:00 05-Oct-2017 HEMO Admission & First Day of Dealings RNS -
11:16 04-Oct-2017 HEMO Result of General Meeting RNS -
07:00 26-Sep-2017 HEMO Investor presentations RNS -
07:00 25-Sep-2017 HEMO Half-year Report RNS -


Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.





Company Information
Updated Monthly
Company address 5 Fleet Place, London, EC4M 7RD, United Kingdom
Company website http://www.he...ogenyx.co...
Market cap(in millions)* £ 11.57
Listing/Admission to trading 09 Nov 2015
Trading service SETSqx
Market Main Market
Listing category Standard Shares
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
18-Nov-17
FTSE index -
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment SSQ3
MiFID Status Regulated Market
Exchange market size 30,000
SEDOL BYX3WZ2
ISIN number GB00BYX3WZ24



HEMOGENYX share news analysis (HEMO)